Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Open Studies | "Esophageal Diseases"
Show Display Options
Rank Status Study
1 Recruiting PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: carboplatin;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Drug: paclitaxel
2 Recruiting A Study of DKN-01 in Combination With Paclitaxel
Conditions: Esophageal Neoplasms;   Adenocarcinoma of the Gastroesophageal Junction;   Gastroesophageal Cancer
Interventions: Drug: DKN-01;   Drug: Paclitaxel

Indicates status has not been verified in more than two years